BullFrog AI is analyzing neuropsychiatric multi-omic data to identify novel targets for major
The nomination of ISM9546 marks a significant milestone for generative artificial intelligence,
The recent events at the Irkutsk Anti-Plague Research Institute demonstrate the significant challenges of managing public perception during a potential highly virulent disease outbreak. When Darya Shipilova, a 27-year-old laboratory specialist, passed away on October 2, the localized incident
By mimicking the bioelectric environment of living bone, this new composite material encourages the body to repair itself using internal biomechanical forces. Orthopedic surgeons have long encountered severe difficulties when treating large segmental bone defects, which are substantial gaps in
The movement toward off-the-shelf immunotherapy is solving the scalability issues that have long
With a focus on advanced machine learning, Isomorphic Labs is attempting to cut years off the
The partnership between Eli Lilly and NVIDIA to build a supercomputer capable of running trillions of molecular simulations is a signal that biopharma’s approach to drug discovery is changing at a s…
The move from research-level discovery to established clinical use is a critical juncture that
The biopharma playbook is being actively rewritten. After years of chasing breakthrough science at
In 2026, boards and customers are asking a direct question: can promising science be turned into
The pharmaceutical sector is entering a decisive phase as obesity therapeutics gain more ground as
A significant challenge in oncology is that nearly one-quarter of breast cancer diagnoses involve aggressive HER2-positive tumors that require immediate and effective neoadjuvant therapy. This aggressive subtype is defined by an overabundance of the HER2 protein, which promotes the rapid growth of
A Software Bill of Materials acts as a critical ingredient list that allows manufacturers to
The move toward fully automated organic synthesis is expected to significantly reduce the time
